The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
This drug helps manage infections and prevent AIDS, but claims it’s a ‘cure’ are not supported
"Currently, there is no therapeutic cure for HIV," Sheryl Zwerski, who holds a Doctor of Nursing Practice and directs the Prevention Sciences Program at the National Institute of Allergy and ...
A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...
Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...
Health experts say lenacapavir could reduce the number of global HIV infections significantly. But it needs to be cheaper to ...
FOX 5 Atlanta on MSN5d
Injectable HIV preventative lenacapavir touted as breakthrough by Emory expertsA new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the ...
Gilead Sciences (GILD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Courtney ...
The incidence of HIV is lower with receipt of twice-yearly subcutaneous lenacapavir compared with daily oral emtricitabine-tenofovir disoproxil fumarate.
FOX 5 spoke exclusively with a participant in a study for a new injectable drug to prevent HIV. Emory University medical ...
Drugmaker Gilead said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates, mostly in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback